🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCompounding & FormulationUSP <797> 2023 revision impact on peptide compounding — July 2024 Page 7

USP <797> 2023 revision impact on peptide compounding — July 2024

sean_dublin Wed, May 21, 2025 at 12:23 PM 37 replies 1,520 viewsPage 7 of 8
Dr.PulmRoch
Member
456
2,345
Jun 2024
Rochester, MN
May 21, 2025 at 10:18 PM#31

Same experience here with USP <797> 2023 revision. mike_mealprep described it perfectly.

27 1rachel_ABQ, traveltech_sara, AttorneyGrant and 24 others
Reply Quote Save Share Report
Dr.DermMIA
Member
456
2,123
May 2024
Miami, FL
May 21, 2025 at 10:35 PM#32
nick_SD_fit said:
Can confirm — exactly what happened to me

This is exactly right. nick_SD_fit articulated what I have been trying to explain to my doctor for months. The USP <797> 2023 revision aspect is the most important factor.

Last edited: May 22, 2025 at 12:35 AM
25 10Dr.RenalNash, LipidDoc_ATL, BariatricNurseD and 22 others
Reply Quote Save Share Report
sean_dublin
Member
212
890
Nov 2024
Dublin, IE
May 21, 2025 at 10:52 PM#33

OP here — wow, did not expect this much response! Thank you all for the thoughtful replies on USP <797> 2023 revision.

To answer sean_dublin: I started tracking everything in a spreadsheet from day 1.

Quick update: I will post a proper update thread soon. Thanks again for the evidence-based discussion — this is exactly why I posted in a science-based community. 🙏

48 10gary_naperville, sean_dublin, hannah_MT and 45 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
ZaraB_AL
Member
456
1,678
Jan 2025
Alabama
May 21, 2025 at 11:09 PM#34

Slightly tangential to USP <797> 2023 revision but dan_philly reminded me — what is the latest on the oral formulations?

I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.

25 23TrialTracker_MD, JennaRN, LabKate and 22 others
Reply Quote Save Share Report
RegAffairsDC
Member
678
3,456
May 2024
Washington, DC
May 21, 2025 at 11:26 PM#35

Agreed. My doctor said the same thing about USP <797> 2023.

47 8gary_naperville, sean_dublin, hannah_MT and 44 others
Reply Quote Save Share Report

Similar Threads

503A vs 503B compounding — regulatory framework explained4 replies
Compounded semaglutide stability: accelerated degradation study results6 replies
Lyophilized vs liquid peptides — stability and bioavailability comparison18 replies
Bacteriostatic water sourcing and sterility considerations8 replies
State-by-state compounding pharmacy regulations — 2026 map8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register